Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37 and ASC39

by | PRNewswire Asia

HONG KONG, June 8, 2026 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces the presentation of three key studies at the American Diabetes Association (ADA) 2026 Scientific Sessions (taking place June 5-8, 2026, in New Orleans,...

Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance

by | PRNewswire Asia

SHANGHAI and HONG KONG, June 8, 2026 /PRNewswire/ — Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...

Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance

by | PRNewswire Asia

SHANGHAI and HONG KONG, June 8, 2026 /PRNewswire/ — Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...

IBA‑UIBC Cup of Bakers 2027 "Golden Statue Cup" China Selection – Hong Kong & Macao SAR Selection Competition Successfully Held in Hong Kong

by | PRNewswire Asia

Competition Highlights Industry Excellence and Strengthens International Exchange in the Baking Sector HONG KONG, June 7, 2026 /PRNewswire/ — The Final of the IBA‑UIBC Cup of Bakers 2027 "Golden Statue Cup" China Selection – Hong Kong & Macao...

Global Rise in Delayed Childbearing and Infertility Drives Demand for Cross-Border Fertility Care

by | PRNewswire Asia

Asian Case Studies Highlight How Regulation, Cost, and Access Are Shaping International Family Choices TAIPEI, June 6, 2026 /PRNewswire/ — Delayed marriage, postponed childbearing, and infertility continue to draw global attention as more individuals and couples...

SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver

by | PRNewswire Asia

Clinical Study Showed Up to 48% Natural Killer Cell Increase with probiotic strain LP281 VANCOUVER, BC, June 6, 2026 /PRNewswire/ — Synbio Tech Inc. (SynbioTech), a global leader in biotechnology solutions, today announced the launch of SYNMUE™, a clinically...